Thomas O. Daniel

10k citations
59 papers · 8.8k · 3 hit papers · h-index 42

Impact in

    • Protein Degradation and Inhibitors
    • Protein Kinase Regulation and GTPase Signaling
    • Angiogenesis and VEGF in Cancer
    • TGF-β signaling in diseases
    • Fibroblast Growth Factor Research
  • Hematology top 1%
    • Multiple Myeloma Research and Treatments

Papers in

    • Angiogenesis and VEGF in Cancer 11
    • Protein Kinase Regulation and GTPase Signaling 10
    • Protein Degradation and Inhibitors 6
    • TGF-β signaling in diseases 5
    • Renal and related cancers 4
    • Fibroblast Growth Factor Research 4
    • Axon Guidance and Neuronal Signaling 9

Thomas O. Daniel

59 papers receiving 8.3k citations

Thomas O. Daniel's Hit Papers

A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase 2016 · 560 citations
5600+13+26Years since publication2505007501k

Peers

Thomas O. Daniel
Comparison fields: 5 of 103
  • Molecular Biology 4.3k
  • Hematology 847
  • Oncology 1k
  • Endocrinology 177
  • Cellular and Molecular Neuroscience 676
Replace Ellen Van Obberghen‐Schilling with:
Ellen Van Obberghen‐Schilling France
Takeshi Urano Japan
Elena Sancho Spain
Jean Y. J. Wang United States
Luis del Peso Spain
Ellen Solomon United Kingdom
Jiro Fujimoto Japan
Dae‐Sik Lim South Korea
Henrik Daub Germany
William Stratford May United States
Thomas O. Daniel relative to Ellen Van Obberghen‐Schilling France Ellen Van Obberghen‐Schilling's profile →
Citations per field
00.5×2×4×5.9×
Ellen Van Obberghen‐Schilling · 1×
Citations per year

Countries citing papers authored by Thomas O. Daniel

Since Specialization
Citations

This map shows the geographic impact of Thomas O. Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas O. Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas O. Daniel more than expected).

Fields of papers citing papers by Thomas O. Daniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas O. Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas O. Daniel. The network helps show where Thomas O. Daniel may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas O. Daniel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas O. Daniel Line = papers co-authored together Thomas O. Daniel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors
Hit paper breakdown →
19861103
2
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Hit paper breakdown →
2016560
3
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN
Hit paper breakdown →
2013545
4 2000519
5 2014444
6 2003347
7 2001336
8 1988298
9
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.
1999265
10 1993258
11 2014256
12 1983253
13 2017237
14 1986214
15
Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
2002213
16 1989208
17 1999179
18 2020177
19 2015167
20 2002137

About Thomas O. Daniel

Thomas O. Daniel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Oncology, Hematology and Cell Biology, having authored 59 papers that have together received 8.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (10 papers), Axon Guidance and Neuronal Signaling (9 papers), Protein Degradation and Inhibitors (6 papers), TGF-β signaling in diseases (5 papers), Renal and related cancers (4 papers), Fibroblast Growth Factor Research (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Molecular Biology (4.3k citations), Hematology (847 citations), Oncology (1k citations), Endocrinology (177 citations) and Cellular and Molecular Neuroscience (676 citations). Thomas O. Daniel has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Lewis T. Williams, Matthew I. Wahl, Douglas Pat Cerretti, Hua Liu, Elke Stein, Uyen Huynh‐Do, Patrice Tremble, Graham F. Carpenter, Jaime A. Escobedo and Dale R. Abrahamson. Their work appears in journals such as Journal of Biological Chemistry, Kidney International, Blood, Proceedings of the National Academy of Sciences and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact